Compass Therapeutics (CMPX) Net Margin (2024)
Compass Therapeutics' Net Margin history spans 1 years, with the latest figure at 1538.35% for Q2 2024.
- For Q2 2024, Net Margin changed N/A year-over-year to 1538.35%; the TTM value through Mar 2025 reached 6884.71%, changed N/A, while the annual FY2024 figure was 6661.76%, N/A changed from the prior year.
- Net Margin for Q2 2024 was 1538.35% at Compass Therapeutics.
- Across five years, Net Margin topped out at 1538.35% in Q2 2024 and bottomed at 1538.35% in Q2 2024.